Pharmaceutical Industry Information Portal

HomeNews

News

Promomed Group received approval for the first drug in its portfolio for treatment of HIV infection

Ritonavir, used for the treatment of HIV infection and viral hepatitis C, received the marketing authorization certificate and became the first drug in the...

Petr Bely: «State support of new markets will help to warm up domestic pharma»

«Pharmaceutical industry can and should be financially self-sufficient,» said Peter Bely, Chairman of the Board of Directors of Promomed Group at the «Strategy Implementation...

“Russian Big Pharma must do a 180 degree turn in its way of thinking” Vikram Punia says

A plenary session where Denis Manturov, Minister of Industry and Trade, and Mikhail Murashko, Minister of Health, participated focused on the issue of “Future...

The second joint laboratory of Promomed Group and Ogarev MSU is now officially opened

On September 30, with the support of Biokhimik JSC of Promomed Group, the scientific and educational laboratory for the synthesis of active pharmaceutical substances...

Russian original medicine product Longidaza® has been patented in Europe

Petrovax Pharm LLC has received a European patent for the original medicine product Longidaza®, which is valid in the UK, Germany, France, Switzerland, Ireland,...

The combination of AstraZeneca and Sputnik Light vaccines in Azerbaijan shows strong neutralizing antibodies growth

R-Pharm Group, the Russian Direct Investment Fund (RDIF) and AstraZeneca announce preliminary virus neutralizing activity results of combined use of the AstraZeneca vaccine (developed...
spot_img

Expert Articles

spot_img